2022-02-24-世界卫生组织-COVID-19_Research_and_Innovation. _Powering_the_world_s_pandemic_response_–_now_and_in_the_future_68页_3mb

Summary of the WHO Report: "COVID-19 Research and Innovation"

Core Content

This report outlines the global research and innovation efforts in response to the COVID-19 pandemic, emphasizing the importance of science, collaboration, and preparedness in combating future health threats. It highlights key achievements in various research areas and underscores the need for continued investment in pandemic preparedness.

Main Points and Key Achievements

1. R&D Achievements Summary

• The WHO R&D Blueprint was established in 2015 to fast-track research for epidemic prevention.
• It focuses on developing effective tests, vaccines, medicines, and social science to save lives and avert crises.
• The UN Research Roadmap for the COVID-19 Recovery supports leveraging science for socio-economic recovery and a more equitable future.
• A global agreement to fight pandemics is being negotiated by the World Health Assembly.

2. Research Areas and Achievements

SARS-CoV-2 at the Human-Animal Interface

• Key Achievements:
  • Evaluated susceptibility of multiple animal species to SARS-CoV-2.
  • Conducted studies in controlled in vivo and in vitro settings.
  • Identified transmission risks in mink and Syrian hamster populations.
  • Developed methods to quantify infectious particles and virus persistence in food and water matrices.
• Contribution:
  • Enhanced understanding of viral transmission between animals and humans.
  • Identified potential reservoirs and the risk of new variants emerging.

Epidemiology of COVID-19

• Key Achievements:
  • Shared epidemiological protocols and dashboards (e.g., SeroTracker).
  • Conducted over 50 meetings with modellers to understand transmission dynamics.
  • Developed study protocols for global epidemiological research.
• Contribution:
  • Improved global data sharing and standardization.
  • Enabled better characterization of trends, transmission, and disease severity.

Outbreak Detection and Prevention

• Key Achievement:
  • Established the WHO Hub for Pandemic and Epidemic Intelligence to enhance data, analytics, and decision-making.
• Contribution:
  • Strengthened global pandemic and epidemic preparedness through better intelligence systems.

Public Health and Social Measures (PHSMs)

• Key Achievements:
  • Launched initiatives to measure the effectiveness of PHSMs.
  • Developed a draft logic model and a global database for PHSM impact studies.
  • Conducted case studies on implementation challenges.
• Contribution:
  • Supported evidence-based policy-making and improved public health responses.

Infodemiology

• Key Achievements:
  • Published a public health research agenda for managing infodemics.
  • Trained over 750 infodemic managers from 132 countries.
  • Developed tools for automated social listening and field infodemiology guides.
• Contribution:
  • Enhanced understanding and management of misinformation during the pandemic.

Vaccines: Research and Development Priorities

• Key Achievements:
  • Established criteria for vaccine prioritization and selection.
  • Updated the Target Product Profile for vaccines.
  • Launched the Solidarity Vaccines Trial with over 30 research sites.
• Contribution:
  • Accelerated vaccine development and deployment.
  • Improved global vaccine access and regulatory harmonization.

Clinical Care Pathway

• Key Achievements:
  • Developed core outcome measures for clinical trials.
  • Established the COVID-19 Platform with data from over 550,000 hospitalized cases.
  • Created a model for prospective meta-analysis of treatment trials.
• Contribution:
  • Standardized data collection and improved global understanding of patient outcomes.

Treatments for Hospitalized Patients

• Key Achievements:
  • Solidarity Therapeutics Trial provided conclusive evidence on repurposed drugs.
  • Launched Solidarity PLUS in 2021 with 52 active countries.
  • Selected three new drugs (artesunate, imatinib, infliximab) for further study.
• Contribution:
  • Improved treatment options and informed clinical decision-making.

Outpatient Therapeutic Trials

• Key Achievements:
  • Framework for pooled data analysis and standardized endpoints.
  • Addressed challenges in trial design and outcome interpretation.
• Contribution:
  • Facilitated the development of outpatient treatment strategies.

Community-Centred Health Emergency Response

• Key Achievements:
  • Advanced research on social and behavioral dynamics.
  • Developed tools for rapid assessment of contextual vulnerability.
  • Strengthened community engagement and data collection mechanisms.
• Contribution:
  • Improved the inclusiveness and effectiveness of public health responses.

Infection, Prevention and Control (IPC) Research

• Key Achievements:
  • Conducted global cost-effectiveness studies on IPC interventions.
  • Improved PPE effectiveness and addressed shortages.
  • Identified environmental factors in virus transmission.
• Contribution:
  • Enhanced IPC strategies to reduce transmission and save resources.

Ethics and Research

• Key Achievements:
  • Developed WHO guidance and policy briefs on ethical issues.
  • Hosted the WHO Pandemic Ethics & Policy Summit.
• Contribution:
  • Supported ethical research practices in public health emergencies.

Regulatory Science and Convergence

• Key Achievements:
  • Assessed and recommended nine new vaccines for EUL.
  • Conducted benchmarking of regulatory systems and issued global alerts.
• Contribution:
  • Streamlined regulatory processes and improved vaccine accessibility.

WHO International Units

• Key Achievements:
  • Established the first WHO International Standards for anti-SARS-CoV-2 antibodies and SARS-CoV-2 RNA.
• Contribution:
  • Standardized immune response evaluation for vaccine development.

Pandemic Preparedness

• Pandemic preparedness is a long-term investment requiring sustained global coordination.
• The report emphasizes the importance of integrating research platforms and systems for future threats.
• Lessons learned from the pandemic should be applied to improve readiness and response mechanisms for future health emergencies.

Conclusion

The report highlights the immense global research effort in combating the pandemic, the development of critical tools and protocols, and the importance of collaboration, data sharing, and community engagement. It also outlines the need for continued research and innovation to address knowledge gaps and strengthen preparedness for future outbreaks.